• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用Judkins左3.5指引导管经桡动脉行右冠状动脉介入治疗的安全性和有效性。

Safety and efficacy of using Judkins left 3.5 guiding catheters for transradial right coronary artery intervention.

作者信息

Yan Z, Xing X-W, Zhang X-G, Wang X, Kuang J-G, Lu Q-H

机构信息

Department of Cardiology, The Second Hospital of Shandong University, Cheeloo College of Medicine, Jinan, Shandong, China.

出版信息

Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2341-2349. doi: 10.26355/eurrev_202303_31769.

DOI:10.26355/eurrev_202303_31769
PMID:37013753
Abstract

OBJECTIVE

There is limited data about the use of a Judkins left (JL) 3.5 guiding catheter for routine transradial right coronary artery (RCA) percutaneous coronary intervention (PCI). This study investigated the safety and efficacy of JL3.5 for RCA PCI.

PATIENTS AND METHODS

Patients with acute coronary syndrome (ACS) who underwent transradial RCA PCI between November 2019 and November 2020 at the Second Hospital of Shandong University were included. The study retrospectively compared JL 3.5 vs. other routine guiding catheters (GCs), including Judkins right (JR) 4.0 and Amplatz (left). Logistic multivariable analysis was used to analyze the factors associated with transradial RCA PCI success rate, in-hospital complications, and extra support.

RESULTS

The study included 311 patients: 136 in the routine GC group and 175 in the JL 3.5 group. There were no significant differences between the two groups regarding in-hospital complications, extra support technics, or success. The multivariable analyses showed that coronary chronic total occlusion (CTO) was negatively associated with intervention success (OR = 0.06, 95% CI: 0.016-0.248, p < 0.001) but positively with extra support (OR = 8.74, 95% CI: 1.518-50.293, p = 0.015). Tortuosity was associated with extra support (OR = 16.50, 95% CI: 3.324-81.589, p = 0.001). In the JL 3.5 group, the left ventricular ejection fraction (OR = 1.11, 95% CI: 1.03-1.20, p = 0.006), CTO (OR = 0.07, 95% CI: 0.008-0.515, p = 0.009), and tortuosity (OR = 0.17, 95% CI: 0.03-0.95, p = 0.043) were independently associated with intervention success.

CONCLUSIONS

JL 3.5 appears to be as safe and effective as the JR 4.0 and Amplatz (left) catheters for RCA PCI. When using the JL 3.5 catheter for RCA PCI, heart function, CTO, and tortuosity should be considered.

摘要

目的

关于使用Judkins左(JL)3.5引导导管进行常规经桡动脉右冠状动脉(RCA)经皮冠状动脉介入治疗(PCI)的数据有限。本研究调查了JL3.5用于RCA PCI的安全性和有效性。

患者与方法

纳入2019年11月至2020年11月在山东大学第二医院接受经桡动脉RCA PCI的急性冠状动脉综合征(ACS)患者。本研究回顾性比较了JL 3.5与其他常规引导导管(GCs),包括Judkins右(JR)4.0和Amplatz(左)。采用逻辑多变量分析来分析与经桡动脉RCA PCI成功率、院内并发症及额外支持相关的因素。

结果

本研究纳入311例患者:常规GC组136例,JL 3.5组175例。两组在院内并发症、额外支持技术或成功率方面无显著差异。多变量分析显示,冠状动脉慢性完全闭塞(CTO)与介入成功率呈负相关(OR = 0.06,95%CI:0.016 - 0.248,p < 0.001),但与额外支持呈正相关(OR = 8.74,95%CI:1.518 - 50.293,p = 0.015)。血管迂曲与额外支持相关(OR = 16.50,95%CI:3.324 - 81.589,p = 0.001)。在JL 3.5组中,左心室射血分数(OR = 1.11,95%CI:1.03 - 1.20,p = 0.006)、CTO(OR = 0.07,95%CI:0.008 - 0.515,p = 0.009)和血管迂曲(OR = 0.17,95%CI:0.03 - 0.95,p = 0.043)与介入成功率独立相关。

结论

对于RCA PCI,JL 3.5似乎与JR 4.0和Amplatz(左)导管一样安全有效。在使用JL 3.5导管进行RCA PCI时,应考虑心功能、CTO和血管迂曲情况。

相似文献

1
Safety and efficacy of using Judkins left 3.5 guiding catheters for transradial right coronary artery intervention.使用Judkins左3.5指引导管经桡动脉行右冠状动脉介入治疗的安全性和有效性。
Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2341-2349. doi: 10.26355/eurrev_202303_31769.
2
Slender Bi-Radial Ping-Pong Technique for Complete Revascularisation of Concomitant CTO and Non-LM Bifurcation Lesions: A Report of Two Cases.细径双轨对向对吻技术在同时处理 CTO 和非左主干分叉病变中的应用:两例报告。
Cardiovasc Revasc Med. 2023 Aug;53S:S302-S306. doi: 10.1016/j.carrev.2022.04.010. Epub 2022 Apr 25.
3
Effectiveness of Left Judkins Catheter as a Single Multipurpose Catheter in Transradial Coronary Angiography From Right Radial Artery: A Randomized Comparison With Conventional Two-Catheter Strategy.左Judkins导管作为经右桡动脉行冠状动脉造影单一多功能导管的有效性:与传统双导管策略的随机对照研究
J Interv Cardiol. 2016 Jun;29(3):257-64. doi: 10.1111/joic.12286. Epub 2016 Mar 1.
4
Access-site complications of transradial percutaneous coronary intervention using sheathless guiding catheters for acute coronary syndrome: a prospective cohort study with radial ultrasound follow-up.经桡动脉途径使用无鞘引导导管行直接经皮冠状动脉介入治疗急性冠状动脉综合征的入路部位并发症:一项前瞻性队列研究并桡动脉超声随访。
Cardiovasc Interv Ther. 2020 Oct;35(4):343-352. doi: 10.1007/s12928-019-00632-7. Epub 2019 Dec 6.
5
Percutaneous Coronary Intervention for Chronic Total Occlusion in Single Coronary Arteries.经皮冠状动脉介入治疗单支冠状动脉慢性完全闭塞病变
Tex Heart Inst J. 2021 Jun 10;48(2). doi: 10.14503/THIJ-19-7023.
6
Transradial Coronary Interventions for Complex Chronic Total Occlusions.经桡动脉入路治疗复杂慢性完全闭塞病变
JACC Cardiovasc Interv. 2017 Feb 13;10(3):235-243. doi: 10.1016/j.jcin.2016.11.003.
7
Transradial percutaneous coronary intervention for chronic total occlusion of coronary artery disease using sheathless standard guiding catheters.使用无鞘标准引导导管经桡动脉行经皮冠状动脉介入治疗冠心病慢性完全闭塞病变
Int J Cardiol Heart Vasc. 2014 Dec 30;6:35-41. doi: 10.1016/j.ijcha.2014.12.001. eCollection 2015 Mar 1.
8
4Fr in 5Fr sheathless technique with standard catheters for transradial coronary interventions: technical challenges and persisting issues.用于经桡动脉冠状动脉介入治疗的采用标准导管的4Fr对5Fr无鞘技术:技术挑战与持续存在的问题
Catheter Cardiovasc Interv. 2015 Apr;85(5):809-15. doi: 10.1002/ccd.25709. Epub 2014 Nov 1.
9
Patient-Specific Three-Dimensional Aortocoronary Model for Percutaneous Coronary Intervention of a Totally Occluded Anomalous Right Coronary Artery.用于完全闭塞性异常右冠状动脉经皮冠状动脉介入治疗的患者特异性三维主动脉冠状动脉模型
J Invasive Cardiol. 2015 Jul;27(7):E139-42.
10
Transradial approach for coronary chronic total occlusion interventions: Insights from a contemporary multicenter registry.经桡动脉途径用于冠状动脉慢性完全闭塞病变介入治疗:来自当代多中心注册研究的见解
Catheter Cardiovasc Interv. 2015 Jun;85(7):1123-9. doi: 10.1002/ccd.25827. Epub 2015 Feb 3.